Compare Nano Dimension Ltd - ADR (NNDM) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nano Dimension Ltd - ADR vs Recursion Pharmaceuticals Inc — how do they compare? Nano Dimension Ltd - ADR trades at $1.49 (market cap $322.08M), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 4.8× Nano Dimension Ltd - ADR's market cap, and Nano Dimension Ltd - ADR is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| NNDM | RXRX | |
|---|---|---|
Market Cap | $322.08M | $1.53B |
Sector | Technology | Health |
52-Week High | $2.14 | $6.79 |
52-Week Low | $1.21 | $2.84 |
Enterprise Value | -$87.26M | $946.50M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nano Dimension (NNDM) trades at $1.49, down 3.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $102.44 million in 2025 but a net loss of $293.30 million, reflecting a negative net income margin of 286.72%. Recent news highlights board changes, cost-saving initiatives, and a proposed business combination with Infinite Epigenetics.
The outlook remains challenging due to persistent losses and negative cash flow, though cost reductions and strategic moves aim to stabilize. Key risks include execution of the turnaround plan and shareholder disputes. Analyst sentiment is mixed, with the stock trading below book value, indicating potential value if operations improve.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
